Part 4/14:
However, subsequent years saw these targets fulfilled, leading to the approval of a staggering $55 billion in stock options and other incentives. Despite this, some shareholders have recently moved to vote against further approval of this compensation plan — effectively voicing disapproval of the very policies that once incentivized growth.
This presents a paradox: how can a plan approved in good faith be ultimately rejected by shareholders? And what does this mean for Elon Musk, who has publicly expressed concern about the inconsistency of shareholder approval changing over time? Musk’s dilemma is emblematic of the broader tension: if shareholders can retroactively oppose previously approved plans, does this undermine trust and stability for key executives?